612381	{Inflammatory bowel disease 23}
612566	{Inflammatory bowel disease 24}
612639	{Inflammatory bowel disease 26}
612796	{Inflammatory bowel disease 27}
601458	{Inflammatory bowel disease 2}
604519	{Inflammatory bowel disease 3}
606675	{Inflammatory bowel disease 4}
606348	{Inflammatory bowel disease 5}
606674	{Inflammatory bowel disease 6}
605225	{Inflammatory bowel disease 7}
606668	{Inflammatory bowel disease 8}
608448	{Inflammatory bowel disease 9}
614680	{Influenza, severe, susceptibility to}
125853	{Insulin resistance, susceptibility to}
603783	{Intelligence QTL1}
610295	{Intelligence QTL3}
610294	{Intelligence QTL3}
603932	{Intervertebral disc disease, susceptibility to}
108010	{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}
601367	{Ischemic stroke, susceptibility to}
608207	{Kala-azar, susceptibility to, 1}
611381	{Kala-azar, susceptibility to, 2}
611382	{Kala-azar, susceptibility to, 3}
148000	{Kaposi sarcoma, susceptibility to}
611775	{Kawasaki disease, susceptibility to}
245300	{Kuru, susceptibility to}
612740	{Lead poisoning, susceptibility to}
308905	{Leber optic atrophy, susceptibility to}
608556	{Legionaire disease, susceptibility to}
609888	{Leprosy, paucibacillary type, susceptibility to}
613223	{Leprosy, protection against}
610988	{Leprosy, susceptibility to, 4}
613223	{Leprosy, susceptibility to, 5}
246300	{Leprosy, susceptibility to}
607572	{Leprosy, susceptibility to}
613407	{Leprosy, susceptiblity to, 6}
613067	{Leukemia, acute lymphoblastic, susceptibility to, 2}
142981	{Leukemia, acute lymphoblastic, susceptibility to}
613065	{Leukemia, acute lymphocytic, susceptibility to, 1}
601626	{Leukemia, acute myeloid, susceptibility to}
601626	{Leukemia, acute myeloid}
612558	{Leukemia, chronic lymphocytic susceptibility to, 4}
612559	{Leukemia, chronic lymphocytic susceptibility to, 5}
609630	{Leukemia, chronic lymphocytic, susceptibility to, 1}
109543	{Leukemia, chronic lymphocytic, susceptibility to, 2}
612557	{Leukemia, chronic lymphocytic, susceptibility to, 3}
125860	{Leukemia, post-chemotherapy, susceptibility to}
127750	{Lewy body dementia, susceptibility to}
608709	{Lipodystrophy, partial, acquired, susceptibility to}
192500	{Long QT syndrome 1, acquired, susceptibility to}
613688	{Long QT syndrome 2, acquired, susceptibility to}
613688	{Long QT syndrome, acquired, reduced susceptibility to}
603776	{Low density lipoprotein cholesterol level QTL 1}
603932	{Lumbar disc degeneration}
603932	{Lumbar disc disease, susceptibility to}
603932	{Lumbar disc herniation, susceptibility to}
612052	{Lung cancer susceptibility 2}
612571	{Lung cancer susceptibility 3}
612593	{Lung cancer susceptibility 4}
614210	{Lung cancer susceptibility 5}
608935	{Lung cancer susceptibility}
211980	{Lung cancer, protection against}
211980	{Lung cancer, resistance to}
211980	{Lung cancer, susceptibility to}
613024	{Lymphoma, follicular, somatic}
153600	{Macroglobulinemia, Waldenstrom, susceptibility to, 1}
610430	{Macroglobulinemia, Waldenstrom, susceptibility to, 2}
611488	{Macular degeneration, age-related, 10}
613784	{Macular degeneration, age-related, 12}
615439	{Macular degeneration, age-related, 13, susceptibility to}
615489	{Macular degeneration, age-related, 14, reduced risk of}
603075	{Macular degeneration, age-related, 1}
610698	{Macular degeneration, age-related, 4}
610149	{Macular degeneration, age-related, 7}
613778	{Macular degeneration, age-related, 8}
611378	{Macular degeneration, age-related, 9}
610149	{Macular degeneration, age-related, neovascular type}
603075	{Macular degeneration, age-related, reduced risk of}
613761	{Macular degeneration, age-related, susceptibility to 5}
125480	{Major affective disorder 1}
609633	{Major affective disorder 3, early onset}
611535	{Major affective disorder 5}
611536	{Major affective disorder 6}
612371	{Major affective disorder-7, susceptibility to}
612357	{Major affective disorder-8, susceptibility to}
612372	{Major affective disorder-9, susceptibility to}
608516	{Major depressive disorder and accelerated response to antidepressant drug treatment}
608516	{Major depressive disorder, response to citalopram therapy in}
611162	{Malaria, cerebral, reduced risk of}
611162	{Malaria, cerebral, susceptibility to}
248310	{Malaria, intensity of infection}
609148	{Malaria, mild, susceptibility to}
611162	{Malaria, protection against}
611162	{Malaria, resistance to}
611162	{Malaria, severe, resistance to}
611162	{Malaria, severe, susceptibility to}
611162	{Malaria, susceptibility to}
611162	{Malaria, vivax, protection against}
145600	{Malignant hyperthermia susceptibility 1}
154275	{Malignant hyperthermia susceptibility 2}
154276	{Malignant hyperthermia susceptibility 3}
600467	{Malignant hyperthermia susceptibility 4}
601887	{Malignant hyperthermia susceptibility 5}
601888	{Malignant hyperthermia susceptibility 6}
156240	{Malignant mesothelioma, susceptibility to}
603855	{Meconium ileus in cystic fibrosis, susceptibility to}
155255	{Medulloblastoma}
155600	{Melanoma, cutaneous malignant, 1}
155601	{Melanoma, cutaneous malignant, 2}
